Clinical trials
Phase 1 Alzheimer Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 7 |
| Not yet recruiting | 5 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xuanwu Hospital, Beijing | 4 |
| Eli Lilly and Company | 3 |
| South China Center For Innovative Pharmaceuticals | 3 |
| Keymed Biosciences Co.Ltd | 2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 2 |
| Anhui Provincial Hospital | 1 |
| Chengdu University of Traditional Chinese Medicine | 1 |
| Chinese PLA General Hospital | 1 |
| Eli Radiopharma | 1 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 23 |
| Plaque, Amyloid | 3 |
| Amyotrophic Lateral Sclerosis | 1 |
| Dementia | 1 |
| Lewy Body Disease | 1 |
| Multiple System Atrophy | 1 |
| Parkinson Disease | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.